AstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer

  • Post author:
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingAstraZeneca Canada Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer

Catastrophic Year for Bay Area's OncoMed Continues as Lead Drug Comes Crashing Down in Phase II Study

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks-down2.jpg" NAME"Catastrophic Year for Bay Area's OncoMed Continues as Lead Drug Comes Crashing Down in Phase II Study" ALT"Catastrophic Year for Bay Area's OncoMed Continues as Lead Drug Comes…

Continue ReadingCatastrophic Year for Bay Area's OncoMed Continues as Lead Drug Comes Crashing Down in Phase II Study

Fast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Fast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ" ALT"Fast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ"May 8, 2017By Mark Terry, BioSpace.com Breaking News Staff...…

Continue ReadingFast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ